Nanoscale Vehicle Created To Battle Cancer Without Harming Healthy Cells
2/10/2013
Devising a method for more precise and less invasive treatment of cancer tumors, a team led by researchers from the UCLA Henry Samueli School of Engineering and Applied Science has developed a degradable nanoscale shell to carry proteins to cancer cells and stunt the growth of tumors without damaging healthy cells...
Tumor-Fighting Protein Stimulated By Compound Aids Cancer Therapy
2/10/2013
A compound that stimulates the production of a tumor-fighting protein may improve the usefulness of the protein in cancer therapy, according to a team of researchers. TRAIL is a natural anti-tumor protein that suppresses tumor development during immune surveillance -- the immune system's process of patrolling the body for cancer cells...
Lymphoma Cells Selectively Destroyed By Experimental Drug Combination
2/09/2013
Laboratory experiments conducted by scientists at Virginia Commonwealth University Massey Cancer Center suggest that a novel combination of the drugs ibrutinib and bortezomib could potentially be an effective new therapy for several forms of blood cancer, including diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL)...
Cancer drugs of the new, molecular generation destroy malignant breast tumors in a targeted manner: They block characteristic molecules on tumor cells - receptors for the hormones estrogen or progesterone, or a co-receptor, called HER2, that binds to many growth factors. But about one in every six breast tumors has none of these receptors...
Lymphoma Cells Selectively Destroyed By Experimental Drug Combination
2/09/2013
Laboratory experiments conducted by scientists at Virginia Commonwealth University Massey Cancer Center suggest that a novel combination of the drugs ibrutinib and bortezomib could potentially be an effective new therapy for several forms of blood cancer, including diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL)...
Stress At Work Very Unlikely To Cause Cancer
2/08/2013
But can cause other contributing factors Work-related stress is not linked to the development of colorectal, lung, breast or prostate cancers, a study published today on bmj.com suggests. Around 90% of cancers are linked to environmental exposures and whilst some exposures are well recognised (such as UV radiation and tobacco smoke), others are not (psychological factors such as stress)...
First and only agent to statistically significantly improve survival in combination with FOLFIRI chemotherapy after an oxaliplatin regimenSanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc...
Sunlight Reduces The Risk Of Esophageal Cancer
2/08/2013
Exposure to sunlight and UV is generally considered to be a risk factor for most forms of cancer, especially skin cancer. However a new study by Australian scientists shows that this general assumption is in fact unfounded. The successful treatment and cure of esophageal cancer depends on several factors...
First and only agent to statistically significantly improve survival in combination with FOLFIRI chemotherapy after an oxaliplatin regimenSanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc...
In Lung Cancer, RNA Promotes Metastasis
2/08/2013
The vast majority - approximately 80 percent - of our DNA does not code for proteins, yet it gets transcribed into RNA. These RNA molecules are called non-coding and fulfill multiple tasks in the cell. Alongside a well-studied group of small RNAs, there is also a class of so-called long non-coding RNAs consisting of more than 200 nucleotides...